Impact of cytolysis following transarterial chemoembolization for hepatocellular carcinoma

about

Impact of cytolysis following transarterial chemoembolization for hepatocellular carcinoma

Item

http://www.wikidata.org/entity/Q36582556

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

Impact of cytolysis following ...... n for hepatocellular carcinoma

@ast

Impact of cytolysis following ...... n for hepatocellular carcinoma

@en

type

Item

label

Impact of cytolysis following ...... n for hepatocellular carcinoma

@ast

Impact of cytolysis following ...... n for hepatocellular carcinoma

@en

prefLabel

Impact of cytolysis following ...... n for hepatocellular carcinoma

@ast

Impact of cytolysis following ...... n for hepatocellular carcinoma

@en

P1476

Impact of cytolysis following ...... n for hepatocellular carcinoma

@en

P2093

Claire Wartelle-Bladou

http://www.w3.org/2001/XMLSchema#string

Gilles Pomier-Layrargues

http://www.w3.org/2001/XMLSchema#string

Louis Bouchard

http://www.w3.org/2001/XMLSchema#string

Marie-Pierre Sylvestre

http://www.w3.org/2001/XMLSchema#string

Philippe Grégoire

http://www.w3.org/2001/XMLSchema#string

Pierre Perrault

http://www.w3.org/2001/XMLSchema#string

Vladimir Marquez

http://www.w3.org/2001/XMLSchema#string

P2860

Management of hepatocellular carcinoma: An update

Global cancer statistics, 2002

Management of hepatocellular carcinoma

Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver

Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial

Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma

Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis

Prognosis of hepatocellular carcinoma: the BCLC staging classification

A comparison of lipiodol chemoembolization and conservative treatment for unresectable hepatocellular carcinoma.

Radiographic response to locoregional therapy in hepatocellular carcinoma predicts patient survival times.

P304

45-52

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3978/J.ISSN.2078-6891.2012.061

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2013-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23450240

http://www.w3.org/2001/XMLSchema#string

P932

3562629

http://www.w3.org/2001/XMLSchema#string